Tumour chemotherapy sensitivity test may predict clinical outcomes in colorectal cancer patients receiving oxaliplatin and fluoropyrimidine-based regimens.

World J Gastrointest Oncol · 2025 · PMC12635669 · PMID 41281494

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

a nonsignificant trendP = 0.055so close (0.05 < p ≤ 0.1)

In contrast, only a nonsignificant trend towards prolonged OS was observed (Figure 2B , P = 0.055).

also in 5,406 other papers

did not reach statistical significanceno p-value reported

Although Cox regression analysis in the training set suggested that ATP-TCA results could serve as an independent prognostic factor of OS in CRC patients, Kaplan-Meier analysis in the validation set indicated only a trend towards improved OS in the sensitive group compared with the resistant group ( P = 0.055), which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.